A mishap with her ankle-foot orthoses was discouraging, but columnist Dagmar Munn quickly happened upon the "mini-miracles" that followed.

Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

After more than a decade of living with her husband's ALS, columnist Kristin Neva has found the equipment to be helpful in ...

Over the past six years, I’ve welcomed over 2,000 people to the ALS News Today Forums. It’s one of my many duties as a forums co-moderator. The other things I do include being alert for spammers, ...

uniQure is planning to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162, its one-time gene therapy for amyotrophic lateral sclerosis (ALS) associated with ...